DPP4 serum activity is elevated in patients with polycystic ovary syndrome, DPP4 serum levels are closely related to anti-Müllerian hormone (AMH) serum levels [54], and the use of DPP4 inhibitors may improve IR [55]. Here, DPP4 is linked to polycystic ovary syndrome.